Skip to main content

Animations

MJFF Publications

2551 - 2560 of 6348 Results
Title
Year
  • Year
  • 2025
  • 2018
  • 2018
  • 2023
  • 2021
  • 2024
  • 2025
  • 2024
  • 2016
  • 2023
  • Summary Details
    OPEN
    Title: APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodies
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.70795
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Post hoc analysis of the Exenatide‐PD trial—Factors that predict response
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.14096
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s disease
    Journal Name: BMC Medical Research Methodology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12874-018-0592-9
    Citation Count: 54
  • Summary Details
    OPEN
    Title: First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary Tale
    Journal Name: Molecular Imaging
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2023/8826977
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/ene.14733
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae453
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12789-0
    Citation Count: 5
  • Summary Details
    OPEN
    Title: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26917
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2016.00271
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Parkin coregulates glutathione metabolism in adult mammalian brain
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01488-4
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.